← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
British Columbia Cancer Agency
Vancouver, BC
$33,784,253
Total funding
19
Grants
Funding over time
peak $3.6M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$33,784,253 · 19
By mechanism
U24$11,668,962 · 2
R01$11,496,553 · 9
U01$8,877,858 · 2
R21$749,658 · 3
U10$508,462 · 1
K22$482,760 · 1
Investigators at British Columbia Cancer Agency
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Cancer transcriptome characterization using massively parallel DNA sequencing$2,176,778
U24 · FY2010 · CA
Cancer transcriptome characterization using massively parallel DNA sequencing$2,119,783
U24 · FY2013 · CA
Cancer transcriptome characterization using massively parallel DNA sequencing$2,096,750
U24 · FY2012 · CA
Cancer transcriptome characterization using massively parallel DNA sequencing$1,999,914
U24 · FY2009 · CA
Cancer transcriptome characterization using massively parallel DNA sequencing$1,967,372
U24 · FY2011 · CA
Improvements in BAC fingerprinting and end sequencing$1,746,890
U01 · FY2003 · HG
Improvements in BAC fingerprinting and end sequencing$1,404,834
U01 · FY2004 · HG
Improvements in BAC fingerprinting and end sequencing$1,164,954
U01 · FY2005 · HG
A Phase II Trial of ACAPHA in Former Smokers with IEN.$1,092,902
U01 · FY2003 · CA
A Phase II Trial of ACAPHA in Former Smokers with IEN.$1,042,339
U01 · FY2002 · CA
A Phase II Trial of ACAPHA in Former Smokers with IEN.$989,903
U01 · FY2004 · CA
A Phase II Trial of ACAPHA in Former Smokers with IEN.$845,564
U01 · FY2005 · CA
A Phase II Trial of ACAPHA in Former Smokers with IEN.$590,472
U01 · FY2006 · CA
Clonal Changes in Oral Lesions of High-Risk Patients$404,429
R01 · FY2007 · DE
Integrative miRNA data analysis for clinical cancer genomics$398,402
U24 · FY2017 · CA
Integrative miRNA data analysis for clinical cancer genomics$394,335
U24 · FY2016 · CA
Optical Techniques and Oral Precancer Management$394,086
R01 · FY2009 · DE
Clonal Changes in Oral Lesions of High-Risk Patients$388,517
R01 · FY2005 · DE
Clonal Changes in Oral Lesions of High-Risk Patients$387,739
R01 · FY2006 · DE
Clonal Changes in Oral Lesions of High-Risk Patients$385,230
R01 · FY2004 · DE